CNDO-109-AANK for AML in First Complete Remission (CR1)

NCT01520558 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

BIOLOGICAL: CNDO-109-AANK Cells

Sponsor

Coronado Biosciences, Inc.